NASDAQ:IKNA
Ikena Oncology, Inc.
- Stock
industry
Biotechnologyexchange
NASDAQ Global Marketwebsite
ikenaoncology.comipo date
Mar 26, 2021full time employees
80currency
USD
Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcr...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus